Degenerative Condition Articles & Analysis
11 news found
Ray Therapeutics, a biotechnology company developing optogenetic gene therapies for patients with retinal degenerative conditions, and Forge Biologics, a gene therapy-focused contract development and manufacturing organization, announced further collaboration for their manufacturing partnership to include clinical stage plasmid DNA production to support Ray ...
Even though both are utilized for pain relief, epidural injections are intended to treat different underlying conditions. Epidural injections are used primarily to treat back pain that transitions to the arms and legs, while facet injections are injected into the joints and intended to aid patients who suffer from degenerative conditions. ...
LimiFlex is an investigational device targeting grade 1 lumbar degenerative spondylolisthesis patients with spinal stenosis. It is designed to restore natural segmental motion and stability after lumbar decompression by augmenting the posterior tension band. ...
“These findings demonstrate the potential of this approach in treating common retinal degenerative conditions such as end-stage age-related macular degeneration, retinitis pigmentosa, and retinal damage due to injury,” said Dr. ...
“Our therapy is intended to replace the midbrain dopaminergic neurons lost in the degenerative condition to rebuild the neural circuit, and thereby restore motor control to Parkinson’s patients. If successful, this could demonstrate for the first time that the effects of degenerative disease are, in principle, reversible.” ...
Dr Kotter was speaking about his work as a neurosurgeon, stem cell biologist and an entrepreneur. Many of the conditions he faces as a doctor, whether they are cancers, genetic or degenerative conditions, need more than a scalpel and screws or cannot be treated successfully with conventional drugs either because they require the regeneration of ...
Bybit.bio
“Our therapy is intended to replace the midbrain dopaminergic neurons lost in the degenerative condition to rebuild the neural circuit, and thereby restore motor control to Parkinson’s patients. This could shift the treatment paradigm for millions of PD patients, as well as demonstrate for the first time that degenerative disease is, ...
A partial rotator cuff tear is one of the most common orthopedic impairments of a person’s shoulder, and can be characterized by a degenerative and often chronic condition found in the supraspinatus tendon. The condition is estimated to affect more than one million patients in developed economies annually. ...
Today the governing Board of the California Institute for Regenerative Medicine (CIRM) awarded $3.9 million to Ankasa Regenerative Therapeutics for a promising approach to treat a degenerative condition that can cause chronic, progressive back pain. As we get older, the bones, joints and ligaments in our back become weak and less able to hold the spinal column ...
Her work in the application of autologous (a patient’s own) stem cell therapy is unparalleled, and includes autoimmune, neurodegenerative, orthopedic and degenerative conditions. To date, the company has worked with more than 10,000 patients and trained more than 700+ physicians worldwide. ...
Comella and her team were the first in the world to publish in-human results in the scientific literature about adipose-derived, autologous stem cells for the treatment of psoriasis — a chronic, painful skin condition that affects more than 7 million Americans every year. Dr. Comella is frequently published in the scientific literature on the practical application of ...